fashion -WSS

fashion

author：leisure time 2025-09-06 04:17:50 - browse：6

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： H5N1 virus can be tracked in retail milk, scientists say

WSS

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Oak Street deal isn't the answer to health care's woes

WuXi Biologics execs register to lobby as Congress comes for the company

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Questions and answers about ramping up H5N1 bird flu vaccine

Fertility clinic egg and embryo storage is a disaster

Wikipedia

fashion

focus

Hepatitis C has a cure — but many Americans still lack access to it

Boston hospital trains restaurant workers on naloxone for overdoses

Bright Health sells Medicare Advantage business to Molina

For longer

Drug repurposing or repositioning? The language matters

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Wildfire smoke exposes gaps in outdoor worker protections

Bird flu surveillance in wastewater gets boost from consortium

Medical leaders decry Supreme Court decision on affirmative action

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

explore

Supreme Court to hear if Covid misinformation is protected speech

Investigation reveals sickle cell patients pressured into sterilizations

Biogen joins immunology wave with $1.15 billion acquisition of HI

Fertility clinic egg and embryo storage is a disaster

Addressing health care workers' trauma can help fight burnout

H5N1 virus can be tracked in retail milk, scientists say

hotspot

hotspot

focus

hotspot